Área de investigación Biología y Biomedicina Instituto CENTRO DE BIOLOGIA MOLECULAR SEVERO OCHOA Importe 93.650,96 € Preclinical development of innovative therapeutics for personalized medicine against Ras-dependent cancer Integrantes: BALBINO JOSE ALARCON SANCHEZ